State Street SPDR S&P Biotech ETF XBI
156.90 USD +4.69 (+3.08%)
At closeNov 9, 2026, 6:08 PM EST
156.90 0.00 0.00%
After hours · Nov 9, 6:08 PM ET
151.00 Day range 157.92
109.28 52-week range 169.89
- YTD
- +28.68%
- 1 year
- +44.00%
- Market cap
- 7.96B
- YTD return
- +28.68%
- 1-year return
- +44.00%
- Volume
- 8.88M
- Avg volume
- 9.08M
- Open
- 153.21
- Previous close
- 152.21
- Day's range
- 151.00 – 157.92
- 52-week range
- 109.28 – 169.89
5Y +30.36 (+23.99%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 155.22
- 200-day average
- 142.31
Next earnings
Consensus EPS estimate 0.00.
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
News
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain? 
Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge 
Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today 
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach 
Economy Grows 63% in Six Years, 30-Year Treasury Lost Almost As Much 
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets 
Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back 
What's Going On With Novavax Stock? 
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs 
Novavax Stock Climbs Monday: What's Going On?
Your note
Sign in to keep a note on XBI — it syncs with the Stock Master app.